Table 1.

Plasmids used in this study

PlasmidBackboneInsertReference
EGFP pEGFP-N1 None  
PH-AKT1-EGFP pEGFP-N1 AKT1(1–164):DPPVAT:EGFP  
PH-AKT1R25C-EGFP pEGFP-N1 AKT1(1–164)-R25C:DPPVAT:EGFP  
PH-PLCD1-mNeonGreen pmNeonGreen-N1 PLCD1(1–170):GVGG:mNeonGreen  
LynN11-FRB-iRFP piRFP713-N1 LYN(1–11):MTOR(2021–2113):iRFP713  
LynN11-mNeonGreenx1 pNeonGreen-N1 LYN(1–11):GVGG:mNeonGreen  
LynN11-mNeonGreenx2  LYN(1–11):GVGG:mNeonGreen:SPVAT:mNeonGreen  
LynN11-mNeonGreenx3  LYN(1–11):GVGG:mNeonGreen:SPVAT:mNeonGreen:SPVAT:mNeonGreen  
mCherry-FKBP-iSH2  mCherry: SGLRSRAALG:FKBP1A(3–108): SA[GGSA]4PRAQAS:Mus musculusPIK3R2(420–615) Suh et al. (2006)  
PH-AKT1-mCherry pmCherry-N1 AKT1(1–164):DPPVAT:mCherry  
PH-BTK-mCherry pmCherry-N1 BTK(1–177):DPPVAT:mCherry Várnai et al. (1999)  
NES-iRFP670-aPHx1 pCMVd3-iRFP670-C1a X. leavis map2k1.L(32–44):PVAT:iRFP670: SGLRSRAQASNSAVDM:CYTH2i2(252–399)-I303E Goulden et al. (2019)  
NES-mCherry-aPHx2 pCMVd3-mCherry-C1a X. leavis map2k1.L(32–44):PVAT:mCherry: SGLRSRAQASNSAVDM:CYTH2i2(252–399)-I303E: GGG​GGA​TCG​GGT​GGT​GTC​GAC​ATG: CYTH2i2(252–399)-I303E Goulden et al. (2019)  
NES-iRFP670-cPHx1 pCMVd3-iRFP670-C1a X. leavis map2k1.L(32–44):PVAT:iRFP670: SGLRSRAGGAGAILS: PLEKHA1(169–329) Goulden et al. (2019)  
NES-mCherry-aPHx3 pCMVd3-mCherry-C1a X. leavis map2k1.L(32–44):PVAT:mCherry: SGLRSRAQASNSTWKMSS:PLEKHA1(169–329):GGSGGSGG: PLEKHA1(169–329): GGSGGSGG: PLEKHA1(169–329) Goulden et al. (2019)  
PlasmidBackboneInsertReference
EGFP pEGFP-N1 None  
PH-AKT1-EGFP pEGFP-N1 AKT1(1–164):DPPVAT:EGFP  
PH-AKT1R25C-EGFP pEGFP-N1 AKT1(1–164)-R25C:DPPVAT:EGFP  
PH-PLCD1-mNeonGreen pmNeonGreen-N1 PLCD1(1–170):GVGG:mNeonGreen  
LynN11-FRB-iRFP piRFP713-N1 LYN(1–11):MTOR(2021–2113):iRFP713  
LynN11-mNeonGreenx1 pNeonGreen-N1 LYN(1–11):GVGG:mNeonGreen  
LynN11-mNeonGreenx2  LYN(1–11):GVGG:mNeonGreen:SPVAT:mNeonGreen  
LynN11-mNeonGreenx3  LYN(1–11):GVGG:mNeonGreen:SPVAT:mNeonGreen:SPVAT:mNeonGreen  
mCherry-FKBP-iSH2  mCherry: SGLRSRAALG:FKBP1A(3–108): SA[GGSA]4PRAQAS:Mus musculusPIK3R2(420–615) Suh et al. (2006)  
PH-AKT1-mCherry pmCherry-N1 AKT1(1–164):DPPVAT:mCherry  
PH-BTK-mCherry pmCherry-N1 BTK(1–177):DPPVAT:mCherry Várnai et al. (1999)  
NES-iRFP670-aPHx1 pCMVd3-iRFP670-C1a X. leavis map2k1.L(32–44):PVAT:iRFP670: SGLRSRAQASNSAVDM:CYTH2i2(252–399)-I303E Goulden et al. (2019)  
NES-mCherry-aPHx2 pCMVd3-mCherry-C1a X. leavis map2k1.L(32–44):PVAT:mCherry: SGLRSRAQASNSAVDM:CYTH2i2(252–399)-I303E: GGG​GGA​TCG​GGT​GGT​GTC​GAC​ATG: CYTH2i2(252–399)-I303E Goulden et al. (2019)  
NES-iRFP670-cPHx1 pCMVd3-iRFP670-C1a X. leavis map2k1.L(32–44):PVAT:iRFP670: SGLRSRAGGAGAILS: PLEKHA1(169–329) Goulden et al. (2019)  
NES-mCherry-aPHx3 pCMVd3-mCherry-C1a X. leavis map2k1.L(32–44):PVAT:mCherry: SGLRSRAQASNSTWKMSS:PLEKHA1(169–329):GGSGGSGG: PLEKHA1(169–329): GGSGGSGG: PLEKHA1(169–329) Goulden et al. (2019)  

All genes (except fluorescent proteins) are human unless otherwise stated. Amino acid linkers are indicated with single letter code.

a

pCMVd3 plasmids are based on the pEGFP-C1 backbone, with the CMV promoter truncated to remove 18 of the 26 putative transcription factor–binding sites in the human cytomegalovirus major intermediate enhancer/promoter (pCMV∆3 as described in Morita et al. [2012]).

or Create an Account

Close Modal
Close Modal